242 related articles for article (PubMed ID: 17443608)
21. Trimethoprim-sulfamethoxazole (cotrimoxazole) desensitization in an HIV-infected 5-yr-old girl.
Gómez-Traseira C; Boyano-Martínez T; Escosa-García L; Pedrosa M; Martín-Muñoz F; Quirce S
Pediatr Allergy Immunol; 2015 May; 26(3):287-289. PubMed ID: 25692246
[No Abstract] [Full Text] [Related]
22. Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis.
Hennessy S; Strom BL; Berlin JA; Brennan PJ
J Gen Intern Med; 1995 Jul; 10(7):380-6. PubMed ID: 7472686
[TBL] [Abstract][Full Text] [Related]
23. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
Briel M; Bucher HC; Boscacci R; Furrer H
Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
[TBL] [Abstract][Full Text] [Related]
24. Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children.
Palusci VJ; Kaul A; Lawrence RM; Haines KA; Kwittken PL
Pediatr Infect Dis J; 1996 May; 15(5):456-60. PubMed ID: 8724071
[TBL] [Abstract][Full Text] [Related]
25. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members.
Mermin J; Lule J; Ekwaru JP; Downing R; Hughes P; Bunnell R; Malamba S; Ransom R; Kaharuza F; Coutinho A; Kigozi A; Quick R
AIDS; 2005 Jul; 19(10):1035-42. PubMed ID: 15958834
[TBL] [Abstract][Full Text] [Related]
26. Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal.
Maynart M; Lièvre L; Sow PS; Kony S; Gueye NF; Bassène E; Metro A; Ndoye I; Ba DS; Coulaud JP; Costagliola D;
J Acquir Immune Defic Syndr; 2001 Feb; 26(2):130-6. PubMed ID: 11242179
[TBL] [Abstract][Full Text] [Related]
27. Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts.
Walter J; Mwiya M; Scott N; Kasonde P; Sinkala M; Kankasa C; Kauchali S; Aldrovandi GM; Thea DM; Kuhn L
J Infect Dis; 2006 Dec; 194(11):1510-8. PubMed ID: 17083035
[TBL] [Abstract][Full Text] [Related]
28. Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi.
Zachariah R; Spielmann MP; Chinji C; Gomani P; Arendt V; Hargreaves NJ; Salaniponi FM; Harries AD
AIDS; 2003 May; 17(7):1053-61. PubMed ID: 12700456
[TBL] [Abstract][Full Text] [Related]
29. Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progression.
Rabaud C; Charreau I; Izard S; Raffi F; Meiffredy V; Leport C; Guillemin F; Yeni P; Aboulker JP;
Scand J Infect Dis; 2001; 33(10):759-64. PubMed ID: 11728044
[TBL] [Abstract][Full Text] [Related]
30. Cotrimoxazole prophylaxis in adults infected with HIV in low-income countries.
Grimwade K; Gilks C
Curr Opin Infect Dis; 2001 Oct; 14(5):507-12. PubMed ID: 11964869
[TBL] [Abstract][Full Text] [Related]
31. [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009].
Ndondoki C; Dabis F; Namale L; Becquet R; Ekouevi D; Bosse-Amani C; Arrivé E; Leroy V
Presse Med; 2011; 40(7-8):e338-57. PubMed ID: 21295437
[TBL] [Abstract][Full Text] [Related]
32. Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control study.
Weigel HM; de Vries E; Regez RM; Henrichs JH; Ten Velden JJ; Frissen PH; van der Meer JT
Scand J Infect Dis; 1997; 29(5):499-502. PubMed ID: 9435040
[TBL] [Abstract][Full Text] [Related]
33. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
34. Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection.
Belchi-Hernandez J; Espinosa-Parra FJ
Ann Allergy Asthma Immunol; 1996 Apr; 76(4):355-8. PubMed ID: 8612118
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study. C.I.S.A.I. Group.
Bonfanti P; Pusterla L; Parazzini F; Libanore M; Cagni AE; Franzetti M; Faggion I; Landonio S; Quirino T
Biomed Pharmacother; 2000 Feb; 54(1):45-9. PubMed ID: 10721462
[TBL] [Abstract][Full Text] [Related]
36. Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?
Koopmans PP; Burger DM
Pharm World Sci; 1998 Dec; 20(6):253-7. PubMed ID: 9972526
[TBL] [Abstract][Full Text] [Related]
37. The independent effect of highly active antiretroviral therapy on severe opportunistic disease incidence and mortality in HIV-infected adults in Côte d'Ivoire.
Losina E; Yazdanpanah Y; Deuffic-Burban S; Wang B; Wolf LL; Messou E; Gabillard D; Seyler C; Freedberg KA; Anglaret X
Antivir Ther; 2007; 12(4):543-51. PubMed ID: 17668563
[TBL] [Abstract][Full Text] [Related]
38. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
Douglas R; Spelman D; Czarny D; O'Hehir RE
Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
[No Abstract] [Full Text] [Related]
39. Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.
Carr A; Penny R; Cooper DA
AIDS; 1993 Jan; 7(1):65-71. PubMed ID: 8442919
[TBL] [Abstract][Full Text] [Related]
40. Hypersensitivity reactions to high-dose co-trimoxazole in HIV-infected Malaysian and Scottish patients.
Pakianathan MR; Kamarulzaman A; Ismail R; McMillan A; Scott GR
AIDS; 1999 Sep; 13(13):1787-8. PubMed ID: 10509585
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
